CTIS: EU Industry Welcomes ‘Landmark Moment’ But Says Issues Still Need Addressing
Executive Summary
EFPIA acknowledges that while the mandatory use of the EU Clinical Trials Information System from today is a significant milestone, it says the usability and functionality of the system need to be enhanced and there are also issues with the Clinical Trials Regulation that need to be fixed.
You may also be interested in...
EudraCT Vs CTIS: How EU Trial Submissions Fared In Run Up To Mandatory Requirements
The European Medicines Agency has published the latest data on the EU clinical trials environment showing how sponsors chose to submit trial applications just ahead of the crucial 31 January 2023 deadline, when the use of the new clinical trials portal became mandatory.
EU Issues More Q&As To Support Compliance With Clinical Trials Regulation
The European Commission has come up with a workaround to address a current lack of functionality in the Clinical Trial Information System, while the European Medicines Agency has addressed technical queries on CTIS and the Clinical Trials Regulation.
EMA Confirms CTIS Ready For Mandatory Use By 31 January Deadline
The European Medicines Agency says that over 80% of the blocking issues and related workarounds affecting the Clinical Trials Information System have been resolved.